查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198092

預裝色譜柱市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Prepacked Chromatography Columns Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，預裝色譜柱市場預計將以 6.9% 的複合年增長率註冊。

COVID-19 大流行對預裝色譜柱市場產生了重大影響。 這是由於各種因素造成的，例如疫苗生產對預裝層析柱的需求增加、生物製藥研發活動增加以及在各種藥物開發過程中的應用增加。 此外，市場上的主要參與者也受益於色譜樹脂需求的激增。 例如，在 2021 年，Repligen 將產生約 1.9 億美元與其 COVID-19 計劃相關的收入，包括用於後期臨床和商業流程的 OPUS 預裝層析柱的收入，包括 COVID-19 疫苗工作流程在內的收益。 因此，COVID-19 的爆發對預裝色譜柱市場的增長產生了重大影響。

對工藝開發、經濟實惠的純化和預裝色譜柱技術進步的需求不斷增長，是推動所研究市場增長的關鍵因素。 在生物製藥行業，預裝柱廣泛應用於工藝開發和生物製造。 預裝色譜柱越來越多地被採用，因為它們可以實現一致的生產，同時卸載昂貴且耗時的裝填程序和相關的驗證協議。

不斷增加的技術創新和產品發布也在推動市場增長。 例如，2022 年 9 月，Tosoh Bioscience GmbH 推出了 Octave BIO 多柱色譜 (MCC) 系統。 該系統與 2020 年 4 月推出的 SkillPak BIO 預裝柱結合使用。 這種新色譜系統的產品推出增加了對公司 SkillPak 預裝柱的需求。 預計這將在預測期內推動市場增長。

因此，增加對藥物研究活動的投資和預裝色譜柱的技術進步有望在預測期內加速市場增長。 然而，色譜柱的技術限制可能會阻礙市場增長。

預裝色譜柱的市場趨勢

親和列增長預期

親和層析是一種允許根據蛋白質的生物學功能而不是它們各自的物理或化學性質來純化蛋白質的技術。 親和層析是一種用於初級捕獲和純化各種蛋白質、核酸、病毒載體、外泌體等的首選技術。 對治療性蛋白質的需求不斷增加，親和膜色譜在生物製藥行業的廣泛使用，以及親和樹脂的不斷創新正在推動這一領域的增長。 例如，2022年2月，Repligen公司推出了AVIPure AAV親和樹脂，有望在基因治療製造中有重要應用。 新推出的樹脂在 OPUS 預裝柱中提供。 此外，生物技術領域的增長補充了對預裝層析柱的需求。 例如，根據 Invest India 在 2022 年發布的數據，印度的生物技術行業在 2022 年增長了 14%，超過 801 億美元。

此外，市場主要參與者的新產品發布和戰略活動對所研究市場的增長產生了積極影響。 例如，2021 年 2 月，Repligen 和 Navigo Proteins 推出了一種親和樹脂，該樹脂也有現成的、預裝的和預認證的 OPUS 柱配置，用於純化 COVID-19 疫苗。 這大大加強了我們的產品組合。 因此，由於產品發布和技術進步，研究部門預計在預測期內將顯著增長。

預計北美將主導市場

由於高研發成本、成熟的實驗室以及預裝色譜柱的現成可用性等因素，預計北美將主導市場。 根據美國研究與製藥製造商協會的數據，2021 年 PhRMA 會員企業的研發投入將創下 1023 億美元的歷史新高。 此外，美國眾多製藥和生物製藥公司的存在也是促進北美研究目標市場增長的重要因素之一。

大量的合作夥伴關係和協作，以及市場參與者集中在美國，也是推動預裝色譜柱市場增長的因素。 2020 年 3 月，Astrea Bioseparations 與 Thermo Fisher Scientific 就預裝生物分離柱簽署了協議。 該非排他性供應協議用於製造包含 Thermo Fisher Scientific 的 CaptureSelect 和 POROS 層析樹脂的預裝 EvolveD 柱。 該合作夥伴關係有望顯著加強公司的產品陣容。 該地區的這種持續發展有望推動北美地區研究市場的增長。

預裝色譜柱市場競爭者分析

由於多家公司在全球和區域運營，預裝層析柱市場有些分散。 競爭格局包括該行業的大型市場，例如 Danaher Corporation (Cytiva)、Repligen Corporation、Merck KGaA、Thermo Fisher Scientific Inc.、Sartorius AG、Bio-Rad Laboratories Inc、Proxcys BV、YMC Europe GmbH、Tosoh Corporation、Astrea Bioseparations . 包括對少數全球公司股票的分析。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 調查先決條件和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 對工藝開發和負擔得起的精煉的需求增加
    • 預裝色譜柱的技術進步
  • 市場製約因素
    • 色譜柱的技術限制
  • 行業吸引力 - 波特五力分析
    • 新進入者的威脅
    • 買家的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按樹脂類型
    • 親和力
    • 離子交換樹脂
    • 其他樹脂類型
  • 按容量
    • 10毫升或更少
    • 10-1000ml
    • 1000毫升或更多
  • 最終用戶
    • 製藥/生物工業
    • 學術研究領域
    • 其他最終用戶
  • 按地區細分
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Danaher Corporation（Cytiva）
    • Repligen Corporation
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Sartorius AG
    • Bio-Rad Laboratories Inc.
    • Proxcys BV
    • YMC Europe GmbH
    • Tosoh Corporation
    • Astrea Bioseparations

第7章 市場機會今後動向

簡介目錄
Product Code: 93223

The prepacked chromatography columns market is expected to register a CAGR of 6.9% over the forecast period.

The COVID-19 pandemic had a significant impact on the prepacked chromatography columns market. This can be attributed to various factors, such as increasing demand for prepacked chromatography columns for vaccine manufacturing, increasing R&D activities for biopharmaceuticals, and increasing application in different drug development processes. Furthermore, the key players in the market also benefitted from the surge in chromatography resin demand. For instance, in 2021, Repligen generated about USD 190 million in revenue related to COVID-19 programs, which included revenue from OPUS prepacked chromatography columns for late-stage clinical and commercial processes, including COVID-19 vaccine workflows. Thus, the COVID-19 outbreak significantly impacted the growth of the prepacked chromatography column market.

Increasing demand for process development, affordable purification, and technological advancements in prepacked chromatography columns are among the significant factors driving the growth of the studied market. In the biopharmaceutical industry, prepacked columns are widely employed for process development and biomanufacturing. Prepacked chromatography columns are increasingly being adopted as it takes away the burden of costly and time-consuming packing procedures and associated validation protocols, thereby ensuring consistent production.

Also, increasing innovation and product launches are driving the market's growth. For instance, in September 2022, Tosoh Bioscience GmbH launched the Octave BIO Multi-Column Chromatography (MCC) system. This system works with SkillPak BIO prepacked columns launched in April 2020. This product launch of a new chromatography system augments the demand for its SkillPak Prepacked Columns. This is expected to propel the market growth over the forecast period.

Thus, increasing investment in pharmaceutical research activities and technological advancements in prepacked chromatography columns are poised to accelerate market growth over the forecast period. However, the technical limitations of the column are likely to impede market growth.

Prepacked Chromatography Columns Market Trends

Affinity Segment Expected to Witness Growth

Affinity chromatography is the technique that allows the purification of proteins based on biological functions rather than individual physical or chemical properties. Affinity chromatography is the preferred approach for the primary capture and purification of different proteins, nucleic acids, viral vectors, and exosomes. Increasing demand for therapeutic protein, wide usage of affinity membrane chromatography in the biopharmaceutical industry, and increasing innovation in affinity resins are propelling the segment's growth. For instance, in February 2022, Repligen Corporation launched AVIPure AAV affinity resins which are anticipated to have a significant application in gene therapy manufacturing. The newly launched resin is available in OPUS prepacked columns. Moreover, the growing biotechnological sector is supplementing the demand for prepacked chromatography columns. For instance, according to the data published by Invest India in 2022, the Indian biotech sector grew by 14% and crossed USD 80.1 billion in 2022.

Furthermore, new product launches and strategic activities by major players in the market are positively affecting the growth of the studied market. For instance, in February 2021, Repligen and Navigo Proteins launched an affinity resin, also available in off-the-shelf, prepacked, and pre-qualified OPUS Columns configuration, for the purification of COVID-19 vaccines. This significantly strengthened its product portfolio. Thus, due to product launches and technological advancements, the studied segment is expected to grow considerably over the forecast period.

North America Expected to Dominate the Market

North America is expected to dominate the market owing to factors such as high R&D spending, well-established research organizations, and the easy availability of prepacked chromatography columns. According to the Pharmaceutical Research and Manufacturers of America, PhRMA member companies' R&D investments reached a record high of USD 102.3 billion in 2021. In addition, the presence of a high number of pharmaceutical and biopharmaceutical companies in the United States is among the key factors contributing to the growth of the studied market in North America.

A high number of partnerships and collaborations and a high concentration of market players in the United States are some of the factors driving the growth of the prepacked chromatography columns market. In March 2020, Astrea Bioseparations came into agreement with Thermo Fisher Scientific for prepacked bioseparation columns. This non-exclusive supply agreement with Thermo Fisher Scientific to manufacture pre-packed EvolveD columns that will include CaptureSelect and POROS chromatography resins of Thermo Fisher Scientific. This collaboration is anticipated to significantly enhance their product offering. Such continuous developments in the region are anticipated to drive the growth of the studied market in the North America region.

Prepacked Chromatography Columns Market Competitor Analysis

The prepacked chromatography columns market is slightly fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few global companies which hold significant market share in the industry, including Danaher Corporation (Cytiva), Repligen Corporation, Merck KGaA, Thermo Fisher Scientific Inc., Sartorius AG, Bio-Rad Laboratories Inc., Proxcys BV, YMC Europe GmbH, Tosoh Corporation, Astrea Bioseparations, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope Of The Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Process Development and Affordable Purification
    • 4.2.2 Technological Advancements in Prepacked Chromatography Columns
  • 4.3 Market Restraints
    • 4.3.1 Technical Limitations of the Column
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Resin Type
    • 5.1.1 Affinity
    • 5.1.2 Ion Exchange
    • 5.1.3 Other Resin Types
  • 5.2 By Volume Type
    • 5.2.1 Below 10 ml
    • 5.2.2 10-1000 ml
    • 5.2.3 Above 1000 ml
  • 5.3 By End-user
    • 5.3.1 Pharmaceutical and Biopharmaceutical Industry
    • 5.3.2 Academic Research
    • 5.3.3 Other End-users
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of the Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of the Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of the South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Danaher Corporation (Cytiva)
    • 6.1.2 Repligen Corporation
    • 6.1.3 Merck KGaA
    • 6.1.4 Thermo Fisher Scientific Inc.
    • 6.1.5 Sartorius AG
    • 6.1.6 Bio-Rad Laboratories Inc.
    • 6.1.7 Proxcys BV
    • 6.1.8 YMC Europe GmbH
    • 6.1.9 Tosoh Corporation
    • 6.1.10 Astrea Bioseparations

7 MARKET OPPORTUNITIES AND FUTURE TRENDS